CKPT Checkpoint Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $0 on the open market.
CKPT revenue and earnings
- Quarter ended Mar 31, 2025: revenue n/a, net income −$11.2M, EPS -0.19
- Quarter ended Dec 31, 2024: revenue n/a, net income −$28.9M, EPS -0.68
- Quarter ended Sep 30, 2024: revenue n/a, net income −$9.73M, EPS -0.23
- Quarter ended Jun 30, 2024: revenue $41.0K, net income −$6.67M, EPS -0.18
Recent CKPT insider trades
- May 29, 2025: Fortress Biotech, Inc. sold 100,000 shares ($129K)
- Apr 2, 2025: Oliviero James F III sold 15,090 shares ($61.0K)
- Apr 1, 2025: Gray William Garrett sold 12,322 shares ($49.9K)
- Feb 10, 2025: Oliviero James F III sold 19,564 shares ($64.0K)